Hematology/Oncology Program Leaders' Message

A Message from Program Leaders

Dear Prospective Applicants:

We invite you to explore the rich offerings afforded by our Hematology/Oncology Fellowship Training Program at Beth Israel Deaconess Medical Center (BIDMC), a major teaching affiliate of Harvard Medical School.

For over 40 years, we have offered rigorous clinical training coupled with world-class faculty expertise and mentorship at the leading-edge of Hematology/Oncology. Reflective of the exponential growth in our understanding of the scientific basis of human disease, comprehensive models of compassionate patient care, and diversity of career opportunities that now exist within our vast discipline, we have evolved our program to include three highly individualized and innovative longitudinal pathways for deliberate career development:

Traditional Hematology/Oncology Track
Hematology/Oncology & Hospice and Palliative Medicine Track
Hematology Track

Each year, our program seeks to recruit seven new exceptionally qualified fellows: six in Hematology/Oncology and Hematology/Oncology & Hospice and Palliative Medicine; one in Hematology.

In 2022, BIDMC was one of nine institutions nationwide selected to receive the prestigious Hematology-Focused Fellowship Training Program (HFFTP) award, granted by the American Society of Hematology (ASH).

In 2023, BIDMC additionally joined an elite cohort of programs nationwide participating in the American Society of Clinical Oncology (ASCO)-sponsored Advancing Innovation in Residency Education (AIRE) ACGME pilot program to offer a combined fellowship training experience in Hematology/Oncology and Hospice and Palliative Medicine.

Our aim is to produce scholars who will devote their careers, in different proportions, to excellence in clinical care, teaching, and clinical/basic research. Every effort is made to tailor the experience to the individual interests and needs of our trainees. We expect that all graduates of our program will become first-class clinicians, teachers, and investigators. In recognition of the program's success in producing physician-scientists, the NIH has provided training grant support to the program for over 30 years.

We have diverse and active clinical investigative initiatives in:

hematopoietic cell transplantation
biologic and immunotherapies
cellular therapies
genitourinary malignancies
breast cancer
lung cancer
head and neck cancer
gastrointestinal malignancies
AIDS-related malignancies
developmental therapeutics
hemostasis and thrombosis

Basic research programs include:

signal transduction and growth regulation
the role of transcription factors in hematopoiesis
molecular analysis of hematopoietic stem cell differentiation
biology of prostate cancer and the molecular basis of hormone-independent prostate cancer growth
biology of AIDS-related malignancies
T-cell receptor biology as applied to gene therapy
hemostasis, thrombosis, and vascular biology
cancer-related thrombosis
platelet biology
molecular retrovirology and HIV-gene therapy
the immunobiology of cytokines
cellular therapies

We welcome you to explore our website in detail and learn more about us. Please feel free to contact us with any questions you may have or to discuss your areas of interest.

Sincerely,
Dr. Deepa Rangachari, Director of Graduate Medical Education & Fellowship Program Director
Dr. Rushad Patell, Associate Fellowship Program Director
Dr. Reed Drews, Emeritus Fellowship Program Director, Associate Program Director Hematology-Focused Fellowship Training Program
Ms. Roshanda Leak, Program Coordinator, Hematology/Oncology & Hematology-Focused Fellowship Training Programs